The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.

Anxiety Clinical Trial

— EMDR  

Official title:

The Effect of Eye Movement Desensitization and Reprocessing Reducing Anxiety, Depressive Symptoms, Blood Pressure, and Heart Rate Variability in Primary Hypertension： A Randomized Controlled Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05836181
• Other study ID #: TSGHNDMC
• Status: Completed
• Phase: N/A
• Start date: February 1, 2014
• Est. completion date: December 28, 2016

Study information

• Verified date: April 2023
• Source: National Defense Medical Center, Taiwan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Eye Movement Desensitization and Reprocessing intervention may improve anxiety, depression, systolic blood pressure and heart rate variability in patients with hypertension.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 110
• Est. completion date: December 28, 2016
• Est. primary completion date: December 10, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

1. age of 20-80 years,

2. diagnosed with primary hypertension as in SBP =130 mmHg or DBP =80 mmHg,

3. and able to read and understand Chinese or Taiwanese and willing to participate in this study,

Exclusion Criteria:

1. . Secondary hypertension

2. . Hypertension Crisis.

Related Conditions & MeSH terms

• Anxiety
• Blood Pressure
• Heart Rate Variability
• Hypertension

Intervention

Behavioral:
• Eye Movement Desensitization and Reprocessing
Effects of Eye Movement Desensitization and Reprocessing on Anxiety, Depression, Quality of Life, Blood Pressure and Heart Rate Variability in Patients with Hypertension.

Locations

Country	Name	City	State
Taiwan	Chen, miao-yi	Taipei	Neihu

Sponsors (1)

Lead Sponsor	Collaborator
Miao-Yi Chen

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Anxiety	HADS-A score	Six month
Primary	depression symptoms	CESD Scale	Six month
Secondary	Blood pressure	Blood pressure	Six month